aluates Reports

$ 0.0

Automative

Global Over the Counter (OTC) Drugs & Dietary Supplements Market Research Report 2024

Published Date: January 2024

Report Code: QYRE-Auto-14N13436

Global Over the Counter OTC Drugs Dietary Supplements Market Research Report 2023

BUY CHAPTERS

Global Over the Counter (OTC) Drugs & Dietary Supplements Market Research Report 2024

Code: QYRE-Auto-14N13436

Report

January 2024

Pages:102

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Over the Counter (OTC) Drugs & Dietary Supplements Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Over the Counter (OTC) Drugs & Dietary Supplements Market

Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription. Dietary supplements are products intended to supplement the diet. They are not drugs and, therefore, are not intended to treat, diagnose, mitigate, prevent, or cure diseases. This report analyzed both OTC drugs and dietary supplements.

The global Over the Counter (OTC) Drugs & Dietary Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Over the Counter (OTC) Drugs & Dietary Supplements, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Over the Counter (OTC) Drugs & Dietary Supplements.

Report Scope

The Over the Counter (OTC) Drugs & Dietary Supplements market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Over the Counter (OTC) Drugs & Dietary Supplements market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Over the Counter (OTC) Drugs & Dietary Supplements companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Over the Counter (OTC) Drugs & Dietary Supplements Market Report

Report Metric	Details
Report Name	Over the Counter (OTC) Drugs & Dietary Supplements Market
CAGR	5%
Segment by Type	Analgesic & Pain Relievers Dermatological Products Cough, Cold, and Flu Products Vitamin Supplements Mineral Supplements Ophthalmic Products
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacy Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer Inc., Novartis International AG, Roche Holding AG, Merck & Co., Inc., Sanofi S.A, Johnson & Johnson, Gilead Sciences, GlaxoSmithKline plc., Bayer Healthcare AG, AstraZeneca plc., Alacer Corp., Alcon Inc., Alfresa Pharma Corporation, Alkalon A/S, Alliance Healthcare, Allergan, Plc., Reckitt Benckiser Plc., Bausch & Lomb, AbbVie Inc., The Colgate-Palmolive Company
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Over the Counter (OTC) Drugs & Dietary Supplements companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Over the Counter (OTC) Drugs & Dietary Supplements Market report?

Ans: The main players in the Over the Counter (OTC) Drugs & Dietary Supplements Market are Pfizer Inc., Novartis International AG, Roche Holding AG, Merck & Co., Inc., Sanofi S.A, Johnson & Johnson, Gilead Sciences, GlaxoSmithKline plc., Bayer Healthcare AG, AstraZeneca plc., Alacer Corp., Alcon Inc., Alfresa Pharma Corporation, Alkalon A/S, Alliance Healthcare, Allergan, Plc., Reckitt Benckiser Plc., Bausch & Lomb, AbbVie Inc., The Colgate-Palmolive Company

What are the Application segmentation covered in the Over the Counter (OTC) Drugs & Dietary Supplements Market report?

Ans: The Applications covered in the Over the Counter (OTC) Drugs & Dietary Supplements Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, Others

What are the Type segmentation covered in the Over the Counter (OTC) Drugs & Dietary Supplements Market report?

Ans: The Types covered in the Over the Counter (OTC) Drugs & Dietary Supplements Market report are Analgesic & Pain Relievers, Dermatological Products, Cough, Cold, and Flu Products, Vitamin Supplements, Mineral Supplements, Ophthalmic Products

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Analgesic & Pain Relievers

1.2.3 Dermatological Products

1.2.4 Cough, Cold, and Flu Products

1.2.5 Vitamin Supplements

1.2.6 Mineral Supplements

1.2.7 Ophthalmic Products

1.3 Market by Application

1.3.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacy

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Perspective (2019-2030)

2.2 Over the Counter (OTC) Drugs & Dietary Supplements Growth Trends by Region

2.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Over the Counter (OTC) Drugs & Dietary Supplements Historic Market Size by Region (2019-2024)

2.2.3 Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Region (2025-2030)

2.3 Over the Counter (OTC) Drugs & Dietary Supplements Market Dynamics

2.3.1 Over the Counter (OTC) Drugs & Dietary Supplements Industry Trends

2.3.2 Over the Counter (OTC) Drugs & Dietary Supplements Market Drivers

2.3.3 Over the Counter (OTC) Drugs & Dietary Supplements Market Challenges

2.3.4 Over the Counter (OTC) Drugs & Dietary Supplements Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Over the Counter (OTC) Drugs & Dietary Supplements Players by Revenue

3.1.1 Global Top Over the Counter (OTC) Drugs & Dietary Supplements Players by Revenue (2019-2024)

3.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Players (2019-2024)

3.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Over the Counter (OTC) Drugs & Dietary Supplements Revenue

3.4 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Concentration Ratio

3.4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Over the Counter (OTC) Drugs & Dietary Supplements Revenue in 2023

3.5 Over the Counter (OTC) Drugs & Dietary Supplements Key Players Head office and Area Served

3.6 Key Players Over the Counter (OTC) Drugs & Dietary Supplements Product Solution and Service

3.7 Date of Enter into Over the Counter (OTC) Drugs & Dietary Supplements Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Over the Counter (OTC) Drugs & Dietary Supplements Breakdown Data by Type

4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Historic Market Size by Type (2019-2024)

4.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Type (2025-2030)

5 Over the Counter (OTC) Drugs & Dietary Supplements Breakdown Data by Application

5.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Historic Market Size by Application (2019-2024)

5.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2019-2030)

6.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2019-2024)

6.4 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2019-2030)

7.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2019-2024)

7.4 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2019-2030)

8.2 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2019-2024)

8.4 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2019-2030)

9.2 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2019-2024)

9.4 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2019-2030)

10.2 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2019-2024)

10.4 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer Inc.

11.1.1 Pfizer Inc. Company Detail

11.1.2 Pfizer Inc. Business Overview

11.1.3 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction

11.1.4 Pfizer Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)

11.1.5 Pfizer Inc. Recent Development

11.2 Novartis International AG

11.2.1 Novartis International AG Company Detail

11.2.2 Novartis International AG Business Overview

11.2.3 Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Introduction

11.2.4 Novartis International AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)

11.2.5 Novartis International AG Recent Development

11.3 Roche Holding AG

11.3.1 Roche Holding AG Company Detail

11.3.2 Roche Holding AG Business Overview

11.3.3 Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Introduction

11.3.4 Roche Holding AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)

11.3.5 Roche Holding AG Recent Development

11.4 Merck & Co., Inc.

11.4.1 Merck & Co., Inc. Company Detail

11.4.2 Merck & Co., Inc. Business Overview

11.4.3 Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction

11.4.4 Merck & Co., Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)

11.4.5 Merck & Co., Inc. Recent Development

11.5 Sanofi S.A

11.5.1 Sanofi S.A Company Detail

11.5.2 Sanofi S.A Business Overview

11.5.3 Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Introduction

11.5.4 Sanofi S.A Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)

11.5.5 Sanofi S.A Recent Development

11.6 Johnson & Johnson

11.6.1 Johnson & Johnson Company Detail

11.6.2 Johnson & Johnson Business Overview

11.6.3 Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Introduction

11.6.4 Johnson & Johnson Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)

11.6.5 Johnson & Johnson Recent Development

11.7 Gilead Sciences

11.7.1 Gilead Sciences Company Detail

11.7.2 Gilead Sciences Business Overview

11.7.3 Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Introduction

11.7.4 Gilead Sciences Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)

11.7.5 Gilead Sciences Recent Development

11.8 GlaxoSmithKline plc.

11.8.1 GlaxoSmithKline plc. Company Detail

11.8.2 GlaxoSmithKline plc. Business Overview

11.8.3 GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction

11.8.4 GlaxoSmithKline plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)

11.8.5 GlaxoSmithKline plc. Recent Development

11.9 Bayer Healthcare AG

11.9.1 Bayer Healthcare AG Company Detail

11.9.2 Bayer Healthcare AG Business Overview

11.9.3 Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Introduction

11.9.4 Bayer Healthcare AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)

11.9.5 Bayer Healthcare AG Recent Development

11.10 AstraZeneca plc.

11.10.1 AstraZeneca plc. Company Detail

11.10.2 AstraZeneca plc. Business Overview

11.10.3 AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction

11.10.4 AstraZeneca plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)

11.10.5 AstraZeneca plc. Recent Development

11.11 Alacer Corp.

11.11.1 Alacer Corp. Company Detail

11.11.2 Alacer Corp. Business Overview

11.11.3 Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Introduction

11.11.4 Alacer Corp. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)

11.11.5 Alacer Corp. Recent Development

11.12 Alcon Inc.

11.12.1 Alcon Inc. Company Detail

11.12.2 Alcon Inc. Business Overview

11.12.3 Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction

11.12.4 Alcon Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)

11.12.5 Alcon Inc. Recent Development

11.13 Alfresa Pharma Corporation

11.13.1 Alfresa Pharma Corporation Company Detail

11.13.2 Alfresa Pharma Corporation Business Overview

11.13.3 Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Introduction

11.13.4 Alfresa Pharma Corporation Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)

11.13.5 Alfresa Pharma Corporation Recent Development

11.14 Alkalon A/S

11.14.1 Alkalon A/S Company Detail

11.14.2 Alkalon A/S Business Overview

11.14.3 Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Introduction

11.14.4 Alkalon A/S Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)

11.14.5 Alkalon A/S Recent Development

11.15 Alliance Healthcare

11.15.1 Alliance Healthcare Company Detail

11.15.2 Alliance Healthcare Business Overview

11.15.3 Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Introduction

11.15.4 Alliance Healthcare Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)

11.15.5 Alliance Healthcare Recent Development

11.16 Allergan, Plc.

11.16.1 Allergan, Plc. Company Detail

11.16.2 Allergan, Plc. Business Overview

11.16.3 Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction

11.16.4 Allergan, Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)

11.16.5 Allergan, Plc. Recent Development

11.17 Reckitt Benckiser Plc.

11.17.1 Reckitt Benckiser Plc. Company Detail

11.17.2 Reckitt Benckiser Plc. Business Overview

11.17.3 Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction

11.17.4 Reckitt Benckiser Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)

11.17.5 Reckitt Benckiser Plc. Recent Development

11.18 Bausch & Lomb

11.18.1 Bausch & Lomb Company Detail

11.18.2 Bausch & Lomb Business Overview

11.18.3 Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Introduction

11.18.4 Bausch & Lomb Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)

11.18.5 Bausch & Lomb Recent Development

11.19 AbbVie Inc.

11.19.1 AbbVie Inc. Company Detail

11.19.2 AbbVie Inc. Business Overview

11.19.3 AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction

11.19.4 AbbVie Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)

11.19.5 AbbVie Inc. Recent Development

11.20 The Colgate-Palmolive Company

11.20.1 The Colgate-Palmolive Company Company Detail

11.20.2 The Colgate-Palmolive Company Business Overview

11.20.3 The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Introduction

11.20.4 The Colgate-Palmolive Company Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)

11.20.5 The Colgate-Palmolive Company Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

Table 1. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Analgesic & Pain Relievers

Table 3. Key Players of Dermatological Products

Table 4. Key Players of Cough, Cold, and Flu Products

Table 5. Key Players of Vitamin Supplements

Table 6. Key Players of Mineral Supplements

Table 7. Key Players of Ophthalmic Products

Table 8. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 10. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2019-2024) & (US$ Million)

Table 11. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Region (2019-2024)

Table 12. Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 13. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Region (2025-2030)

Table 14. Over the Counter (OTC) Drugs & Dietary Supplements Market Trends

Table 15. Over the Counter (OTC) Drugs & Dietary Supplements Market Drivers

Table 16. Over the Counter (OTC) Drugs & Dietary Supplements Market Challenges

Table 17. Over the Counter (OTC) Drugs & Dietary Supplements Market Restraints

Table 18. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Players (2019-2024) & (US$ Million)

Table 19. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Players (2019-2024)

Table 20. Global Top Over the Counter (OTC) Drugs & Dietary Supplements Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Over the Counter (OTC) Drugs & Dietary Supplements as of 2023)

Table 21. Ranking of Global Top Over the Counter (OTC) Drugs & Dietary Supplements Companies by Revenue (US$ Million) in 2023

Table 22. Global 5 Largest Players Market Share by Over the Counter (OTC) Drugs & Dietary Supplements Revenue (CR5 and HHI) & (2019-2024)

Table 23. Key Players Headquarters and Area Served

Table 24. Key Players Over the Counter (OTC) Drugs & Dietary Supplements Product Solution and Service

Table 25. Date of Enter into Over the Counter (OTC) Drugs & Dietary Supplements Market

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2019-2024) & (US$ Million)

Table 28. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Type (2019-2024)

Table 29. Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 30. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Type (2025-2030)

Table 31. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2019-2024) & (US$ Million)

Table 32. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Application (2019-2024)

Table 33. Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 34. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Application (2025-2030)

Table 35. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2019-2024) & (US$ Million)

Table 40. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2025-2030) & (US$ Million)

Table 41. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 42. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2019-2024) & (US$ Million)

Table 43. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2025-2030) & (US$ Million)

Table 44. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2019-2024) & (US$ Million)

Table 46. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2025-2030) & (US$ Million)

Table 47. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 48. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2025-2030) & (US$ Million)

Table 50. Pfizer Inc. Company Detail

Table 51. Pfizer Inc. Business Overview

Table 52. Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product

Table 53. Pfizer Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024) & (US$ Million)

Table 54. Pfizer Inc. Recent Development

Table 55. Novartis International AG Company Detail

Table 56. Novartis International AG Business Overview

Table 57. Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Product

Table 58. Novartis International AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024) & (US$ Million)

Table 59. Novartis International AG Recent Development

Table 60. Roche Holding AG Company Detail

Table 61. Roche Holding AG Business Overview

Table 62. Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Product

Table 63. Roche Holding AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024) & (US$ Million)

Table 64. Roche Holding AG Recent Development

Table 65. Merck & Co., Inc. Company Detail

Table 66. Merck & Co., Inc. Business Overview

Table 67. Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product

Table 68. Merck & Co., Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024) & (US$ Million)

Table 69. Merck & Co., Inc. Recent Development

Table 70. Sanofi S.A Company Detail

Table 71. Sanofi S.A Business Overview

Table 72. Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Product

Table 73. Sanofi S.A Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024) & (US$ Million)

Table 74. Sanofi S.A Recent Development

Table 75. Johnson & Johnson Company Detail

Table 76. Johnson & Johnson Business Overview

Table 77. Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Product

Table 78. Johnson & Johnson Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024) & (US$ Million)

Table 79. Johnson & Johnson Recent Development

Table 80. Gilead Sciences Company Detail

Table 81. Gilead Sciences Business Overview

Table 82. Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Product

Table 83. Gilead Sciences Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024) & (US$ Million)

Table 84. Gilead Sciences Recent Development

Table 85. GlaxoSmithKline plc. Company Detail

Table 86. GlaxoSmithKline plc. Business Overview

Table 87. GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Product

Table 88. GlaxoSmithKline plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024) & (US$ Million)

Table 89. GlaxoSmithKline plc. Recent Development

Table 90. Bayer Healthcare AG Company Detail

Table 91. Bayer Healthcare AG Business Overview

Table 92. Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Product

Table 93. Bayer Healthcare AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024) & (US$ Million)

Table 94. Bayer Healthcare AG Recent Development

Table 95. AstraZeneca plc. Company Detail

Table 96. AstraZeneca plc. Business Overview

Table 97. AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Product

Table 98. AstraZeneca plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024) & (US$ Million)

Table 99. AstraZeneca plc. Recent Development

Table 100. Alacer Corp. Company Detail

Table 101. Alacer Corp. Business Overview

Table 102. Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Product

Table 103. Alacer Corp. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024) & (US$ Million)

Table 104. Alacer Corp. Recent Development

Table 105. Alcon Inc. Company Detail

Table 106. Alcon Inc. Business Overview

Table 107. Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product

Table 108. Alcon Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024) & (US$ Million)

Table 109. Alcon Inc. Recent Development

Table 110. Alfresa Pharma Corporation Company Detail

Table 111. Alfresa Pharma Corporation Business Overview

Table 112. Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Product

Table 113. Alfresa Pharma Corporation Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024) & (US$ Million)

Table 114. Alfresa Pharma Corporation Recent Development

Table 115. Alkalon A/S Company Detail

Table 116. Alkalon A/S Business Overview

Table 117. Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Product

Table 118. Alkalon A/S Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024) & (US$ Million)

Table 119. Alkalon A/S Recent Development

Table 120. Alliance Healthcare Company Detail

Table 121. Alliance Healthcare Business Overview

Table 122. Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Product

Table 123. Alliance Healthcare Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024) & (US$ Million)

Table 124. Alliance Healthcare Recent Development

Table 125. Allergan, Plc. Company Detail

Table 126. Allergan, Plc. Business Overview

Table 127. Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product

Table 128. Allergan, Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024) & (US$ Million)

Table 129. Allergan, Plc. Recent Development

Table 130. Reckitt Benckiser Plc. Company Detail

Table 131. Reckitt Benckiser Plc. Business Overview

Table 132. Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product

Table 133. Reckitt Benckiser Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024) & (US$ Million)

Table 134. Reckitt Benckiser Plc. Recent Development

Table 135. Bausch & Lomb Company Detail

Table 136. Bausch & Lomb Business Overview

Table 137. Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Product

Table 138. Bausch & Lomb Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024) & (US$ Million)

Table 139. Bausch & Lomb Recent Development

Table 140. AbbVie Inc. Company Detail

Table 141. AbbVie Inc. Business Overview

Table 142. AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product

Table 143. AbbVie Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024) & (US$ Million)

Table 144. AbbVie Inc. Recent Development

Table 145. The Colgate-Palmolive Company Company Detail

Table 146. The Colgate-Palmolive Company Business Overview

Table 147. The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Product

Table 148. The Colgate-Palmolive Company Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024) & (US$ Million)

Table 149. The Colgate-Palmolive Company Recent Development

Table 150. Research Programs/Design for This Report

Table 151. Key Data Information from Secondary Sources

Table 152. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type: 2023 VS 2030

Figure 3. Analgesic & Pain Relievers Features

Figure 4. Dermatological Products Features

Figure 5. Cough, Cold, and Flu Products Features

Figure 6. Vitamin Supplements Features

Figure 7. Mineral Supplements Features

Figure 8. Ophthalmic Products Features

Figure 9. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 10. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application: 2023 VS 2030

Figure 11. Hospital Pharmacies Case Studies

Figure 12. Retail Pharmacies Case Studies

Figure 13. Online Pharmacy Case Studies

Figure 14. Others Case Studies

Figure 15. Over the Counter (OTC) Drugs & Dietary Supplements Report Years Considered

Figure 16. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 17. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 18. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Region: 2023 VS 2030

Figure 19. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Players in 2023

Figure 20. Global Top Over the Counter (OTC) Drugs & Dietary Supplements Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Over the Counter (OTC) Drugs & Dietary Supplements as of 2023)

Figure 21. The Top 10 and 5 Players Market Share by Over the Counter (OTC) Drugs & Dietary Supplements Revenue in 2023

Figure 22. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2019-2030)

Figure 24. United States Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Canada Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2019-2030)

Figure 28. Germany Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. France Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. U.K. Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Italy Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Russia Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Nordic Countries Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Region (2019-2030)

Figure 36. China Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Japan Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. South Korea Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. India Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Australia Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2019-2030)

Figure 44. Mexico Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Brazil Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2019-2030)

Figure 48. Turkey Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Pfizer Inc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)

Figure 51. Novartis International AG Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)

Figure 52. Roche Holding AG Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)

Figure 53. Merck & Co., Inc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)

Figure 54. Sanofi S.A Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)

Figure 55. Johnson & Johnson Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)

Figure 56. Gilead Sciences Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)

Figure 57. GlaxoSmithKline plc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)

Figure 58. Bayer Healthcare AG Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)

Figure 59. AstraZeneca plc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)

Figure 60. Alacer Corp. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)

Figure 61. Alcon Inc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)

Figure 62. Alfresa Pharma Corporation Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)

Figure 63. Alkalon A/S Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)

Figure 64. Alliance Healthcare Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)

Figure 65. Allergan, Plc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)

Figure 66. Reckitt Benckiser Plc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)

Figure 67. Bausch & Lomb Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)

Figure 68. AbbVie Inc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)

Figure 69. The Colgate-Palmolive Company Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Over the Counter (OTC) Drugs & Dietary Supplements Market Research Report 2024

Published Date: January 2024

Report Code: QYRE-Auto-14N13436

Global Over the Counter (OTC) Drugs & Dietary Supplements Market Research Report 2024

FEATURED COMPANIES

Over the Counter (OTC) Drugs & Dietary Supplements Market Size

Over the Counter (OTC) Drugs & Dietary Supplements Market

Report Scope

Scope of Over the Counter (OTC) Drugs & Dietary Supplements Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Over the Counter (OTC) Drugs & Dietary Supplements Market report?

What are the Application segmentation covered in the Over the Counter (OTC) Drugs & Dietary Supplements Market report?

What are the Type segmentation covered in the Over the Counter (OTC) Drugs & Dietary Supplements Market report?

FEATURED COMPANIES